UPDATE: Affy s Stock Surges After UK Court Ruling, OGT to Appeal | GenomeWeb

This story has been updated from a previous version.

NEW YORK, Nov 1 – As Affymetrix stock continued to soar on the news of a UK Court's decision that it had a license to Oxford Gene Technology's microarray patents, OGT said it intended to petition the House of Lords for an appeal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."